|
May 25
|
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
|
|
May 14
|
Does Prime Medicine, Inc. (PRME) Have the Potential to Rally 133.64% as Wall Street Analysts Expect?
|
|
May 13
|
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
|
|
May 12
|
Alphabet Bought Up Two Slumping Stocks
|
|
May 11
|
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth?
|
|
May 10
|
Prime Medicine Inc (PRME) Q1 2024 Earnings: Navigates Through Challenges with Strategic Developments
|
|
May 10
|
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 8
|
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
|
|
May 3
|
What Makes Prime Medicine, Inc. (PRME) a New Buy Stock
|
|
May 1
|
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
|
|
Apr 30
|
Prime Medicine gets green light for trials of first-ever prime editing drug
|
|
Apr 29
|
Prime gets FDA green light to begin first trial test of ‘prime editing’
|
|
Apr 29
|
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
|
|
Apr 23
|
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
|
|
Mar 27
|
2 Magnificent Growth Stocks With Room to Run
|
|
Mar 14
|
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
|
|
Jan 9
|
Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know
|
|
Jan 2
|
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 19
|
Better Growth Stock: Archer Aviation or Prime Medicine?
|
|
Nov 30
|
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
|